News Update: GenoBioTX and Crown Bioscience Sign Global Cooperation Agreement

                                                            20240627

image.pngGenoBioTX and Crown Bioscience have entered into a five-year global partnership, enhancing their existing collaboration. This agreement leverages GenoBioTX's vast animal model resources and Crown Bioscience's specialized immuno-oncology platform to deliver superior model resources and CRO services.

 

GenoBioTX will share its library of over 11,000 standardized genetically engineered mouse models with Crown Bioscience and provide development services for these models and cell lines. This collaboration aims to advance immuno-oncology research and bridge the gap between scientific discovery and clinical application, invigorating the global biopharmaceutical industry.

 

About Crown Bioscience

 

Founded in 2006, Crown Bioscience is now a subsidiary of JSR Life Sciences. Headquartered in San Diego, California, Crown Bioscience operates 13 subsidiaries and R&D centers across the Americas, Europe, and Asia, employing over 1,200 people globally. As a preclinical CRO, Crown Bioscience specializes in providing preclinical and translational medicine platform services, focusing on oncology and immuno-oncology drug discovery and development. The company boasts an extensive, commercially viable PDX model library worldwide. Exclusively licensed by the Netherlands' HUB, Crown Bioscience offers tumor organoid commercialization services. Notably, in 2021, Crown Bioscience contributed to the approval of 6 out of 13 oncology drugs by the FDA. Crown Bioscience assists clients in selecting effective cancer drug candidates, ensuring timely and effective treatment for patients.


あなたも好きかも

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

詳細
Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

詳細